Less Than Two-Thirds Of Insured Patients With Viremic HCV Infection Received Treatment With DAAs From 2014-2021, Study Shows
December 20, 2022
Healio (12/19, Burba) reports, “Less than two-thirds of insured patients with viremic hepatitis C virus infection received treatment with direct-acting antivirals from 2014 to 2021, with a sharp decline in diagnoses and treatment reported during the COVID...